Axel Kleemann, PhD in Chemistry, is former Director of Degussa AG Organic Chemical Research, former Executive Director of ASTA Medica AG, and Professor at the University of Frankfurt (Germany), with more than 40 years experience in the corporate pharma sector.

Bernhard Kutscher, PhD in Chemistry, is Professor at the Technical University Munich (Germany), with more than 35 years of professional experience as manager for various healthcare, pharma and chemical companies.

Stomatological Preparations (A01)

Drugs for Acid-Related Disorders (A02)

Drugs for Functional Gastrointestinal Disorders (A03)

Antiemetics and Antinauseants (A04)

Bile and Liver Therapy (A05)

Drugs for Constipation (A06)

Antidiarrheals, Intestinal Antiinflammatory and Antiinfective Agents (A07)

Anti-Obesity Drugs (A08)

Antidiabetic Drugs (A10)

Vitamins (A11)

Anabolic Agents for Systemic Use (A14)

Other Alimentary Tract and Metabolism Products (A16)

Antithrombotics and Antihemorrhagics (B01, B02)

Cardiovascular System (C)

Dermatologicals, 1. Introduction (D)

Dermatologicals, 2. Antifungals, Emollients and Protectives, and Antipruritics for Dermatological Use (D05, D06, D07)

Dermatologicals, 3. Antipsoriatics, Antibiotics and Chemotherapeutics, and Corticosteroids for Dermatological Use (D05, D06, D07)

Dermatologicals, 4. Antiseptics and Disinfectants, Anti-Acne Preparations, and Other Dermatological Preparations (D08, D10, D11)

Genitourinary System and Sex Hormones (G)

Hormone Therapeutcis - Systemic Hormonal Preparations, Excluding Reproductive Hormones and Insulins (H)

Antiinfectives for Systemic Use, 1. Antibacterials (J01)

Antiinfectives for Systemic Use, 2. Antimycotics (Antifungals) and Antimycobacterials (J02, J04)

Antiinfectives for Systemic Use, 3. Antivirals (J05)

Antineoplastic and Immunomodulating Agents (L01, L02)

Drugs for Musculo-Skeletal System (M)

Anesthetics (N01)

Analgesics (N02)

Antiepileptics (N03)

Anti-Parkinson Drugs (N04)

Antipsychotics (Neuroleptics, N05A)

Anxiolytics (N05B)

Hypnotics and Sedatives (N05C)

Antidepressants (N06A)

Psychostimulants (N06B)

Anti-Dementia Drugs (N06D)

Parasympathomimetics, Anti-Addiction Drugs, Anti-Vertigo Drugs, and Other Nervous System Drugs (N07)

Antiparasitics (PC)

Respiratory Disorders, 1. Introduction (R)

Respiratory Disorders, 2. Nasal Preparations and Decongestants for Topical Use (R01)

Respiratory Disorders, 3. Throat Preparations (R02)

Respiratory Disorders, 4. Inhalants for Obstructive Airway Diseases (R03)

Respiratory Disorders, 5. Oral Drugs for Obstructive Airway Diseases (R03)

Respiratory Disorders, 6. Cough and Cold Preparations (R05)

Respiratory Disorders, 7. Antihistamines for Systemic Use (R06)

Respiratory Disorders, 8. Respiratory Stimulants (R07)

Sensory Organs, 1. Ophthalmologicals (S01)

Sensory Organs, 2. Otologicals (S02)

All Other Therapeutic Products and Contrast Media (V03, V08)